{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:54:37Z","timestamp":1785455677753,"version":"3.56.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The growth arrest and DNA damage inducible 45A (GADD45A) is a multifaceted protein associated with stress signaling and cellular injury. Aside its well-established tumor suppressor activity, recent studies point to additional roles for GADD45A, including the regulation of catabolic and anabolic pathways, or the prevention of inflammation, fibrosis, and oxidative stress in some tissues and organs. However, little is known about its function in cardiac disease. In this study, we aimed to evaluate the role of GADD45A in the heart by using mice with constitutive and systemic deletion of <jats:italic>Gadd45a<\/jats:italic>, and cardiac cells of human origin. <jats:italic>Gadd45a<\/jats:italic> suppression in knockout mice triggered cardiac fibrosis, inflammation, and apoptosis, and these changes correlated with an hyperactivation of the pro-inflammatory and pro-fibrotic transcription factors activator protein-1 (AP-1), nuclear factor-\u03baB (NF-\u03baB), and signal transducer and activator of transcription 3 (STAT3). Deletion of <jats:italic>Gadd45a<\/jats:italic> also resulted in substantial cardiac hypertrophy, which negatively impacted cardiac morphology and function in knockout mice. Consistent with this, GADD45A overexpression in human AC16 cardiomyocytes partially prevented the inflammatory and fibrotic responses induced by tumor necrosis factor-\u03b1 (TNF-\u03b1). Overall, data presented in this study highlight an important role for GADD45A in the heart, since it may prevent inflammation, fibrosis, and apoptosis, and, by this means, preserve cardiac function and performance. Since fibrosis and inflammation are crucial in the progression of cardiac hypertrophy and subsequent heart failure, these results suggest that promoting the activity of this protein might be a promising therapeutic strategy to slow down the progression of these deleterious diseases.<\/jats:p>","DOI":"10.1007\/s00018-025-05704-x","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:33:13Z","timestamp":1745980393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["GADD45A suppression contributes to cardiac remodeling by promoting inflammation, fibrosis and hypertrophy"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-9984","authenticated-orcid":false,"given":"Adel","family":"Rostami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-8207","authenticated-orcid":false,"given":"Xavier","family":"Palomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pizarro-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Montori-Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Valenzuela-Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e0tima","family":"Crispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Hurl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Nistal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"5704_CR1","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.4161\/cc.5.13.2902","volume":"5","author":"A Lal","year":"2006","unstructured":"Lal A, Gorospe M (2006) Egad, more forms of gene regulation: the gadd45a story. Cell Cycle 5:1422\u20131425. https:\/\/doi.org\/10.4161\/cc.5.13.2902","journal-title":"Cell Cycle"},{"key":"5704_CR2","first-page":"1675","volume":"11","author":"JM Kearsey","year":"1995","unstructured":"Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA (1995) Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene 11:1675\u20131683","journal-title":"Oncogene"},{"key":"5704_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.arr.2011.09.003","volume":"11","author":"AA Moskalev","year":"2012","unstructured":"Moskalev AA, Smit-McBride Z, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Tacutu R, Fraifeld VE (2012) Gadd45 proteins: relevance to aging, longevity and age-related pathologies. Ageing Res Rev 11:51\u201366. https:\/\/doi.org\/10.1016\/j.arr.2011.09.003","journal-title":"Ageing Res Rev"},{"key":"5704_CR4","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1093\/nar\/gkt223","volume":"41","author":"M Gao","year":"2013","unstructured":"Gao M, Li X, Dong W, Jin R, Ma H, Yang P, Hu M, Li Y, Hao Y, Yuan S, Huang J, Song L (2013) Ribosomal protein S7 regulates arsenite-induced GADD45alpha expression by attenuating MDM2-mediated GADD45alpha ubiquitination and degradation. Nucleic Acids Res 41:5210\u20135222. https:\/\/doi.org\/10.1093\/nar\/gkt223","journal-title":"Nucleic Acids Res"},{"key":"5704_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/138920309788922216","volume":"10","author":"M Gao","year":"2009","unstructured":"Gao M, Guo N, Huang C, Song L (2009) Diverse roles of GADD45alpha in stress signaling. Curr Protein Pept Sci 10:388\u2013394. https:\/\/doi.org\/10.2174\/138920309788922216","journal-title":"Curr Protein Pept Sci"},{"key":"5704_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/13802","volume":"23","author":"MC Hollander","year":"1999","unstructured":"Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ (1999) Jr.: genomic instability in Gadd45a-deficient mice. Nat Genet 23:176\u2013184. https:\/\/doi.org\/10.1038\/13802","journal-title":"Nat Genet"},{"key":"5704_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/med.22015","volume":"44","author":"X Palomer","year":"2024","unstructured":"Palomer X, Salvador JM, Grinan-Ferre C, Barroso E, Pallas M, Vazquez-Carrera M (2024) GADD45A: with or without you. Med Res Rev 44:1375\u20131403. https:\/\/doi.org\/10.1002\/med.22015","journal-title":"Med Res Rev"},{"key":"5704_CR8","first-page":"7305","volume":"62","author":"J Hildesheim","year":"2002","unstructured":"Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace AJ Jr. (2002) Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res 62:7305\u20137315","journal-title":"Cancer Res"},{"key":"5704_CR9","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.18632\/oncotarget.14580","volume":"8","author":"K Mukherjee","year":"2017","unstructured":"Mukherjee K, Sha X, Magimaidas A, Maifrede S, Skorski T, Bhatia R, Hoffman B, Liebermann DA (2017) Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia. Oncotarget 8:10809\u201310821. https:\/\/doi.org\/10.18632\/oncotarget.14580","journal-title":"Oncotarget"},{"key":"5704_CR10","first-page":"2487","volume":"61","author":"MC Hollander","year":"2001","unstructured":"Hollander MC, Kovalsky O, Salvador JM, Kim KE, Patterson AD, Haines DC, Fornace AJ Jr. (2001) Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res 61:2487\u20132491","journal-title":"Cancer Res"},{"key":"5704_CR11","doi-asserted-by":"publisher","first-page":"8448","DOI":"10.1158\/0008-5472.CAN-06-2013","volume":"66","author":"JS Tront","year":"2006","unstructured":"Tront JS, Hoffman B, Liebermann DA (2006) Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66:8448\u20138454. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2013","journal-title":"Cancer Res"},{"key":"5704_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4614-8289-5_1","volume":"793","author":"JM Salvador","year":"2013","unstructured":"Salvador JM, Brown-Clay JD, Fornace AJ Jr. (2013) Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol 793:1\u201319. https:\/\/doi.org\/10.1007\/978-1-4614-8289-5_1","journal-title":"Adv Exp Med Biol"},{"key":"5704_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ol.2015.3882","volume":"11","author":"H Ishiguro","year":"2016","unstructured":"Ishiguro H, Kimura M, Takahashi H, Tanaka T, Mizoguchi K, Takeyama H (2016) GADD45A expression is correlated with patient prognosis in esophageal cancer. Oncol Lett 11:277\u2013282. https:\/\/doi.org\/10.3892\/ol.2015.3882","journal-title":"Oncol Lett"},{"key":"5704_CR14","doi-asserted-by":"publisher","unstructured":"Liu S, Cai P, You W, Yang M, Tu Y, Zhou Y, Valencak TG, Xiao Y, Wang Y, Shan T (2025) Enhancement of gut barrier integrity by a Bacillus subtilis secreted metabolite through the GADD45A-Wnt\/\u03b2-catenin pathway. iMeta 2025:e70005. https:\/\/doi.org\/10.1002\/imt2.70005","DOI":"10.1002\/imt2.70005"},{"key":"5704_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s1074-7613(02)00302-3","volume":"16","author":"JM Salvador","year":"2002","unstructured":"Salvador JM, Hollander MC, Nguyen AT, Kopp JB, Barisoni L, Moore JK, Ashwell JD, Fornace AJ Jr. (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16:499\u2013508. https:\/\/doi.org\/10.1016\/s1074-7613(02)00302-3","journal-title":"Immunity"},{"key":"5704_CR16","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.bbadis.2017.08.017","volume":"1863","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Takahashi S, Hu X, Lu Y, Fujimori N, Golla S, Fang ZZ, Aoyama T, Krausz KW, Gonzalez FJ (2017) Growth arrest and DNA damage-inducible 45alpha protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Biochim Biophys Acta Mol Basis Dis 1863:3170\u20133182. https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5704_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1182\/blood.2024024072","volume":"144","author":"N Hassan","year":"2024","unstructured":"Hassan N, Yi H, Malik B, Gaspard-Boulinc L, Samaraweera SE, Casolari DA, Seneviratne J, Balachandran A, Chew T, Duly A, Carter DR, Cheung BB, Norris M, Haber M, Kavallaris M, Marshall GM, Zhang XD, Liu T, Wang J, Liebermann DA, D\u2019Andrea RJ, Wang JY (2024) Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4\/HOXA9-dependent AML. Blood 144:84\u201398. https:\/\/doi.org\/10.1182\/blood.2024024072","journal-title":"Blood"},{"key":"5704_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41419-020-02802-5","volume":"11","author":"W You","year":"2020","unstructured":"You W, Xu Z, Sun Y, Valencak TG, Wang Y, Shan T (2020) GADD45alpha drives brown adipose tissue formation through upregulating PPARgamma in mice. Cell Death Dis 11:585. https:\/\/doi.org\/10.1038\/s41419-020-02802-5","journal-title":"Cell Death Dis"},{"key":"5704_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12915-023-01713-z","volume":"21","author":"W You","year":"2023","unstructured":"You W, Liu S, Li J, Tu Y, Shan T (2023) GADD45A regulates subcutaneous fat deposition and lipid metabolism by interacting with Stat1. BMC Biol 21:212. https:\/\/doi.org\/10.1186\/s12915-023-01713-z","journal-title":"BMC Biol"},{"key":"5704_CR20","doi-asserted-by":"publisher","first-page":"27290","DOI":"10.1074\/jbc.M112.374777","volume":"287","author":"SM Ebert","year":"2012","unstructured":"Ebert SM, Dyle MC, Kunkel SD, Bullard SA, Bongers KS, Fox DK, Dierdorff JM, Foster ED, Adams CM (2012) Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy. J Biol Chem 287:27290\u201327301. https:\/\/doi.org\/10.1074\/jbc.M112.374777","journal-title":"J Biol Chem"},{"key":"5704_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jcsm.13134","volume":"14","author":"W You","year":"2023","unstructured":"You W, Liu S, Ji J, Ling D, Tu Y, Zhou Y, Chen W, Valencak TG, Wang Y, Shan T (2023) Growth arrest and DNA damage-inducible alpha regulates muscle repair and fat infiltration through ATP synthase F1 subunit alpha. J Cachexia Sarcopenia Muscle 14:326\u2013341. https:\/\/doi.org\/10.1002\/jcsm.13134","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5704_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.31083\/j.rcm2305165","volume":"23","author":"A Caturano","year":"2022","unstructured":"Caturano A, Vetrano E, Galiero R, Salvatore T, Docimo G, Epifani R, Alfano M, Sardu C, Marfella R, Rinaldi L, Sasso FC (2022) Cardiac hypertrophy: from pathophysiological mechanisms to heart failure development. Rev Cardiovasc Med 23:165. https:\/\/doi.org\/10.31083\/j.rcm2305165","journal-title":"Rev Cardiovasc Med"},{"key":"5704_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1083\/jcb.201207033","volume":"199","author":"P Teekakirikul","year":"2012","unstructured":"Teekakirikul P, Padera RF, Seidman JG, Seidman CE (2012) Hypertrophic cardiomyopathy: translating cellular cross talk into therapeutics. J Cell Biol 199:417\u2013421. https:\/\/doi.org\/10.1083\/jcb.201207033","journal-title":"J Cell Biol"},{"key":"5704_CR24","doi-asserted-by":"publisher","first-page":"27152","DOI":"10.31083\/RCM27152","volume":"26","author":"P Skorka","year":"2025","unstructured":"Skorka P, Piotrowski J, Bakinowska E, Kielbowski K, Pawlik A (2025) The role of signalling pathways in myocardial fibrosis in hypertrophic cardiomyopathy. Rev Cardiovasc Med 26:27152. https:\/\/doi.org\/10.31083\/RCM27152","journal-title":"Rev Cardiovasc Med"},{"key":"5704_CR25","doi-asserted-by":"publisher","first-page":"C144","DOI":"10.1093\/eurheartjsupp\/suad017","volume":"25","author":"D Corrado","year":"2023","unstructured":"Corrado D, Zorzi A, Cipriani A, Bauce B, Bariani R, Brunetti G, Graziano F, De Lazzari M, Mattesi G, Migliore F, Pilichou K, Rigato I, Rizzo S, Thiene G, Perazzolo Marra M, Basso C (2023) Scarring\/arrhythmogenic cardiomyopathy. Eur Heart J Suppl 25:C144\u2013C154. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suad017","journal-title":"Eur Heart J Suppl"},{"key":"5704_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.amjcard.2022.06.017","volume":"179","author":"BA Maron","year":"2022","unstructured":"Maron BA, Wang RS, Carnethon MR, Rowin EJ, Loscalzo J, Maron BJ, Maron MS (2022) What causes hypertrophic cardiomyopathy?? Am J Cardiol 179:74\u201382. https:\/\/doi.org\/10.1016\/j.amjcard.2022.06.017","journal-title":"Am J Cardiol"},{"key":"5704_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12872-021-02147-7","volume":"21","author":"J Xu","year":"2021","unstructured":"Xu J, Liu X, Dai Q (2021) Integration of transcriptomic data identifies key hallmark genes in hypertrophic cardiomyopathy. BMC Cardiovasc Disord 21:330. https:\/\/doi.org\/10.1186\/s12872-021-02147-7","journal-title":"BMC Cardiovasc Disord"},{"key":"5704_CR28","doi-asserted-by":"publisher","first-page":"e49077","DOI":"10.1371\/journal.pone.0049077","volume":"7","author":"N Wang","year":"2012","unstructured":"Wang N, Yang C, Xie F, Sun L, Su X, Wang Y, Wei R, Zhang R, Li X, Yang B, Ai J (2012) Gadd45alpha: a novel diabetes-associated gene potentially linking diabetic cardiomyopathy and baroreflex dysfunction. PLoS ONE 7:e49077. https:\/\/doi.org\/10.1371\/journal.pone.0049077","journal-title":"PLoS ONE"},{"key":"5704_CR29","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath JC, Lilley E (2015) Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172:3189\u20133193. https:\/\/doi.org\/10.1111\/bph.12955","journal-title":"Br J Pharmacol"},{"key":"5704_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41392-020-0114-1","volume":"5","author":"X Palomer","year":"2020","unstructured":"Palomer X, Roman-Azcona MS, Pizarro-Delgado J, Planavila A, Villarroya F, Valenzuela-Alcaraz B, Crispi F, Sepulveda-Martinez A, Miguel-Escalada I, Ferrer J, Nistal JF, Garcia R, Davidson MM, Barroso E, Vazquez-Carrera M (2020) SIRT3-mediated Inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation. Signal Transduct Target Ther 5:14. https:\/\/doi.org\/10.1038\/s41392-020-0114-1","journal-title":"Signal Transduct Target Ther"},{"key":"5704_CR31","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.ijcard.2012.06.006","volume":"167","author":"X Palomer","year":"2013","unstructured":"Palomer X, Capdevila-Busquets E, \u00c1lvarez-Guardia D, Barroso E, Pallas M, Camins A, Davidson MM, Planavila A, Villarroya F, Vazquez-Carrera M (2013) Resveratrol induces nuclear factor-kappaB activity in human cardiac cells. Int J Cardiol 167:2507\u20132516. https:\/\/doi.org\/10.1016\/j.ijcard.2012.06.006","journal-title":"Int J Cardiol"},{"key":"5704_CR32","doi-asserted-by":"publisher","first-page":"2746304","DOI":"10.1155\/2022\/2746304","volume":"2022","author":"J Alatic","year":"2022","unstructured":"Alatic J, Suran D, Vokac D, Naji FH (2022) Mitral annular plane systolic excursion (MAPSE) as a predictor of atrial fibrillation recurrence in patients after pulmonary vein isolation. Cardiol Res Pract 2022:2746304. https:\/\/doi.org\/10.1155\/2022\/2746304","journal-title":"Cardiol Res Pract"},{"key":"5704_CR33","doi-asserted-by":"publisher","unstructured":"Pibarot P, Dumesnil JG (2010) Longitudinal myocardial shortening in aortic stenosis: ready for prime time after 30 years of research? Heart. 96:95\u201396. https:\/\/doi.org\/10.1136\/hrt.2009.177345","DOI":"10.1136\/hrt.2009.177345"},{"key":"5704_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.yjmcc.2004.12.002","volume":"38","author":"Y Taniyama","year":"2005","unstructured":"Taniyama Y, Ito M, Sato K, Kuester C, Veit K, Tremp G, Liao R, Colucci WS, Ivashchenko Y, Walsh K, Shiojima I (2005) Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol 38:375\u2013385. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.12.002","journal-title":"J Mol Cell Cardiol"},{"key":"5704_CR35","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1073\/pnas.0712235105","volume":"105","author":"C Suzuki","year":"2008","unstructured":"Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A, Wagner G (2008) PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci U S A 105:3274\u20133279. https:\/\/doi.org\/10.1073\/pnas.0712235105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5704_CR36","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/nar\/gkm099","volume":"35","author":"F Vikhanskaya","year":"2007","unstructured":"Vikhanskaya F, Lee MK, Mazzoletti M, Broggini M, Sabapathy K (2007) Cancer-derived p53 mutants suppress p53-target gene expression\u2013potential mechanism for gain of function of mutant p53. Nucleic Acids Res 35:2093\u20132104. https:\/\/doi.org\/10.1093\/nar\/gkm099","journal-title":"Nucleic Acids Res"},{"key":"5704_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati G, Schirone L, Chimenti I, Yee D, Biondi-Zoccai G, Volpe M, Sciarretta S (2017) An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res 113:378\u2013388. https:\/\/doi.org\/10.1093\/cvr\/cvx011","journal-title":"Cardiovasc Res"},{"key":"5704_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cardiores.2003.08.014","volume":"60","author":"S Cardin","year":"2003","unstructured":"Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S (2003) Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 60:315\u2013325. https:\/\/doi.org\/10.1016\/j.cardiores.2003.08.014","journal-title":"Cardiovasc Res"},{"key":"5704_CR39","doi-asserted-by":"publisher","unstructured":"Vanhoutte D, Schips TG, Vo A, Grimes KM, Baldwin TA, Brody MJ, Accornero F, Sargent MA, Molkentin JD Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun 2021, 12:3928. https:\/\/doi.org\/10.1038\/s41467-021-24215-4","DOI":"10.1038\/s41467-021-24215-4"},{"key":"5704_CR40","doi-asserted-by":"publisher","first-page":"41083","DOI":"10.1074\/jbc.M111.258715","volume":"286","author":"RP Zhang","year":"2011","unstructured":"Zhang RP, Shao JZ, Xiang LX (2011) GADD45A protein plays an essential role in active DNA demethylation during terminal osteogenic differentiation of adipose-derived mesenchymal stem cells. J Biol Chem 286:41083\u201341094. https:\/\/doi.org\/10.1074\/jbc.M111.258715","journal-title":"J Biol Chem"},{"key":"5704_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/jmcb\/mjx026","volume":"9","author":"B Wang","year":"2017","unstructured":"Wang B, Fu X, Zhu MJ, Du M (2017) Retinoic acid inhibits white adipogenesis by disrupting GADD45A-mediated Zfp423 DNA demethylation. J Mol Cell Biol 9:338\u2013349. https:\/\/doi.org\/10.1093\/jmcb\/mjx026","journal-title":"J Mol Cell Biol"},{"key":"5704_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41366-021-00955-7","volume":"46","author":"RM Pontes-da-Silva","year":"2022","unstructured":"Pontes-da-Silva RM, de Souza Marinho T, de Macedo Cardoso LE, Mandarim-de-Lacerda CA, Aguila MB (2022) Obese mice weight loss role on nonalcoholic fatty liver disease and Endoplasmic reticulum stress treated by a GLP-1 receptor agonist. Int J Obes (Lond) 46:21\u201329. https:\/\/doi.org\/10.1038\/s41366-021-00955-7","journal-title":"Int J Obes (Lond)"},{"key":"5704_CR43","doi-asserted-by":"publisher","first-page":"e171772","DOI":"10.1172\/jci.insight.171772","volume":"8","author":"GR Marcotte","year":"2023","unstructured":"Marcotte GR, Miller MJ, Kunz HE, Ryan ZC, Strub MD, Vanderboom PM, Heppelmann CJ, Chau S, Von Ruff ZD, Kilroe SP, McKeen AT, Dierdorff JM, Stern JI, Nath KA, Grueter CE, Lira VA, Judge AR, Rasmussen BB, Nair KS, Lanza IR, Ebert SM, Adams CM (2023) GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle. JCI Insight 8:e171772. https:\/\/doi.org\/10.1172\/jci.insight.171772","journal-title":"JCI Insight"},{"key":"5704_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/jcm8060801","volume":"8","author":"RN Li","year":"2019","unstructured":"Li RN, Lin YZ, Pan YC, Lin CH, Tseng CC, Sung WY, Wu CC, Ou TT, Tsai WC, Yen JH (2019) GADD45a and GADD45b genes in rheumatoid arthritis and systemic lupus erythematosus patients. J Clin Med 8:801. https:\/\/doi.org\/10.3390\/jcm8060801","journal-title":"J Clin Med"},{"key":"5704_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","volume":"10","author":"EL Kessler","year":"2019","unstructured":"Kessler EL, Rivaud MR, Vos MA, van Veen Table (2019) Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease. Biol Sex Differ 10:7. https:\/\/doi.org\/10.1186\/s13293-019-0223-0","journal-title":"Biol Sex Differ"},{"key":"5704_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.tips.2018.02.010","volume":"39","author":"X Palomer","year":"2018","unstructured":"Palomer X, Pizarro-Delgado J, Vazquez-Carrera M (2018) Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?? Trends Pharmacol Sci 39:452\u2013467. https:\/\/doi.org\/10.1016\/j.tips.2018.02.010","journal-title":"Trends Pharmacol Sci"},{"key":"5704_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/ijms19030913","volume":"19","author":"X Palomer","year":"2018","unstructured":"Palomer X, Barroso E, Pizarro-Delgado J, Pena L, Botteri G, Zarei M, Aguilar D, Montori-Grau M, Vazquez-Carrera M (2018) PPARbeta\/delta: A key therapeutic target in metabolic disorders. Int J Mol Sci 19:913\u2013926. https:\/\/doi.org\/10.3390\/ijms19030913","journal-title":"Int J Mol Sci"},{"key":"5704_CR48","doi-asserted-by":"publisher","unstructured":"Men L, Hui W, Guan X, Song T, Wang X, Zhang S, Chen X (2020) Cardiac transcriptome analysis reveals Nr4a1 mediated glucose metabolism dysregulation in response to High-Fat diet. Genes (Basel) 11. https:\/\/doi.org\/10.3390\/genes11070720","DOI":"10.3390\/genes11070720"},{"key":"5704_CR49","doi-asserted-by":"publisher","first-page":"101257","DOI":"10.1016\/j.molmet.2021.101257","volume":"53","author":"S Yu","year":"2021","unstructured":"Yu S, Meng S, Xiang M, Ma H (2021) Phosphoenolpyruvate Carboxykinase in cell metabolism: roles and mechanisms beyond gluconeogenesis. Mol Metab 53:101257. https:\/\/doi.org\/10.1016\/j.molmet.2021.101257","journal-title":"Mol Metab"},{"key":"5704_CR50","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X, Salvado L, Barroso E, Vazquez-Carrera M (2013) An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol 168:3160\u20133172. https:\/\/doi.org\/10.1016\/j.ijcard.2013.07.150","journal-title":"Int J Cardiol"},{"key":"5704_CR51","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/cvr\/cvn327","volume":"81","author":"X Palomer","year":"2009","unstructured":"Palomer X, \u00c1lvarez-Guardia D, Rodriguez-Calvo R, Coll T, Laguna JC, Davidson MM, Chan TO, Feldman AM, Vazquez-Carrera M (2009) TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res 81:703\u2013712. https:\/\/doi.org\/10.1093\/cvr\/cvn327","journal-title":"Cardiovasc Res"},{"key":"5704_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00018-018-2912-y","volume":"76","author":"C Li","year":"2019","unstructured":"Li C, Ming Y, Wang Z, Xu Q, Yao L, Xu D, Tang Y, Lei X, Li X, Mao Y (2019) GADD45alpha alleviates acetaminophen-induced hepatotoxicity by promoting AMPK activation. Cell Mol Life Sci 76:129\u2013145. https:\/\/doi.org\/10.1007\/s00018-018-2912-y","journal-title":"Cell Mol Life Sci"},{"key":"5704_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff J, Tian R (2017) Metabolism in cardiomyopathy: every substrate matters. Cardiovasc Res 113:411\u2013421. https:\/\/doi.org\/10.1093\/cvr\/cvx017","journal-title":"Cardiovasc Res"},{"key":"5704_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.apsb.2020.08.015","volume":"11","author":"X Cai","year":"2021","unstructured":"Cai X, Feng Y, Xu M, Yu C, Xie W (2021) Gadd45b is required in part for the anti-obesity effect of constitutive Androstane receptor (CAR). Acta Pharm Sin B 11:434\u2013441. https:\/\/doi.org\/10.1016\/j.apsb.2020.08.015","journal-title":"Acta Pharm Sin B"},{"key":"5704_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/bbrc.2000.2760","volume":"272","author":"YW Yi","year":"2000","unstructured":"Yi YW, Kim D, Jung N, Hong SS, Lee HS, Bae I (2000) Gadd45 family proteins are coactivators of nuclear hormone receptors. Biochem Biophys Res Commun 272:193\u2013198. https:\/\/doi.org\/10.1006\/bbrc.2000.2760","journal-title":"Biochem Biophys Res Commun"},{"key":"5704_CR56","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2021.03.004","volume":"27","author":"X Palomer","year":"2021","unstructured":"Palomer X, Aguilar-Recarte D, Garcia R, Nistal JF, Vazquez-Carrera M (2021) Sirtuins: to be or not to be in diabetic cardiomyopathy. Trends Mol Med 27:554\u2013571. https:\/\/doi.org\/10.1016\/j.molmed.2021.03.004","journal-title":"Trends Mol Med"},{"key":"5704_CR57","doi-asserted-by":"publisher","first-page":"110692","DOI":"10.1016\/j.mce.2019.110692","volume":"503","author":"L Huang","year":"2020","unstructured":"Huang L, Zhou Y, Chen Z, Zhang M, Zhan Z, Wang L, Liu L (2020) Severe hypoglycemia exacerbates myocardial dysfunction and metabolic remodeling in diabetic mice. Mol Cell Endocrinol 503:110692. https:\/\/doi.org\/10.1016\/j.mce.2019.110692","journal-title":"Mol Cell Endocrinol"},{"key":"5704_CR58","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.bbalip.2016.01.019","volume":"1861","author":"X Palomer","year":"2016","unstructured":"Palomer X, Barroso E, Zarei M, Botteri G, Vazquez-Carrera M (2016) PPARbeta\/delta and lipid metabolism in the heart. Biochim Biophys Acta 1861:1569\u20131578. https:\/\/doi.org\/10.1016\/j.bbalip.2016.01.019","journal-title":"Biochim Biophys Acta"},{"key":"5704_CR59","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245\u20131250. https:\/\/doi.org\/10.1038\/nm1116","journal-title":"Nat Med"},{"key":"5704_CR60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.112.094524","volume":"126","author":"Z Pan","year":"2012","unstructured":"Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene\/transforming growth factor-beta1 pathway. Circulation 126:840\u2013850. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.094524","journal-title":"Circulation"},{"key":"5704_CR61","doi-asserted-by":"publisher","first-page":"652097","DOI":"10.1155\/2011\/652097","volume":"2011","author":"O Lorenzo","year":"2011","unstructured":"Lorenzo O, Picatoste B, Ares-Carrasco S, Ramirez E, Egido J, Tunon J (2011) Potential role of nuclear factor kappab in diabetic cardiomyopathy. Mediators Inflamm 2011:652097. https:\/\/doi.org\/10.1155\/2011\/652097","journal-title":"Mediators Inflamm"},{"key":"5704_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00774-003-0410-1","volume":"21","author":"NH Moritani","year":"2003","unstructured":"Moritani NH, Kubota S, Eguchi T, Fukunaga T, Yamashiro T, Takano-Yamamoto T, Tahara H, Ohyama K, Sugahara T, Takigawa M (2003) Interaction of AP-1 and the Ctgf gene: a possible driver of chondrocyte hypertrophy in growth cartilage. J Bone Min Metab 21:205\u2013210. https:\/\/doi.org\/10.1007\/s00774-003-0410-1","journal-title":"J Bone Min Metab"},{"key":"5704_CR63","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1074\/jbc.M112.418335","volume":"288","author":"F Yang","year":"2013","unstructured":"Yang F, Zhang W, Li D, Zhan Q (2013) Gadd45a suppresses tumor angiogenesis via Inhibition of the mTOR\/STAT3 protein pathway. J Biol Chem 288:6552\u20136560. https:\/\/doi.org\/10.1074\/jbc.M112.418335","journal-title":"J Biol Chem"},{"key":"5704_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-2187-3-15","volume":"3","author":"DA Liebermann","year":"2008","unstructured":"Liebermann DA, Hoffman B (2008) Gadd45 in stress signaling. J Mol Signal 3:15. https:\/\/doi.org\/10.1186\/1750-2187-3-15","journal-title":"J Mol Signal"},{"key":"5704_CR65","doi-asserted-by":"publisher","unstructured":"Grinan-Ferre C, Jarne-Ferrer J, Bellver-Sanchis A, Ribalta-Vilella M, Barroso E, Salvador JM, Jurado-Aguilar J, Palomer X, Vazquez-Carrera M, Pallas M (2024) Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer\u2019s Disease Hallmarks. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25052595","DOI":"10.3390\/ijms25052595"},{"key":"5704_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12916-024-03593-8","volume":"22","author":"B Zhang","year":"2024","unstructured":"Zhang B, Wu Y, Zhou C, Xie J, Zhang Y, Yang X, Xiao J, Wang DW, Shan C, Zhou X, Xiang Y, Yang B (2024) Hyperactivation of ATF4\/TGF-beta1 signaling contributes to the progressive cardiac fibrosis in arrhythmogenic cardiomyopathy caused by DSG2 variant. BMC Med 22:361. https:\/\/doi.org\/10.1186\/s12916-024-03593-8","journal-title":"BMC Med"},{"key":"5704_CR67","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/ehf2.14404","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, He Q, He CY, Cai C, Chen Z, Duan JZ (2023) Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis. ESC Heart Fail 10:2510\u20132523. https:\/\/doi.org\/10.1002\/ehf2.14404","journal-title":"ESC Heart Fail"},{"key":"5704_CR68","doi-asserted-by":"publisher","first-page":"588347","DOI":"10.3389\/fcvm.2020.588347","volume":"7","author":"S Saadat","year":"2020","unstructured":"Saadat S, Noureddini M, Mahjoubin-Tehran M, Nazemi S, Shojaie L, Aschner M, Maleki B, Abbasi-Kolli M, Rajabi Moghadam H, Alani B, Mirzaei H (2020) Pivotal role of TGF-beta\/Smad signaling in cardiac fibrosis: Non-coding RNAs as effectual players. Front Cardiovasc Med 7:588347. https:\/\/doi.org\/10.3389\/fcvm.2020.588347","journal-title":"Front Cardiovasc Med"},{"key":"5704_CR69","doi-asserted-by":"publisher","first-page":"109826","DOI":"10.1016\/j.cellsig.2020.109826","volume":"77","author":"A Hanna","year":"2021","unstructured":"Hanna A, Humeres C, Frangogiannis NG (2021) The role of Smad signaling cascades in cardiac fibrosis. Cell Signal 77:109826. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109826","journal-title":"Cell Signal"},{"key":"5704_CR70","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.3748\/wjg.v22.i9.2779","volume":"22","author":"L Hong","year":"2016","unstructured":"Hong L, Sun QF, Xu TY, Wu YH, Zhang H, Fu RQ, Cai FJ, Zhou QQ, Zhou K, Du QW, Zhang D, Xu S, Ding JG (2016) New role and molecular mechanism of Gadd45a in hepatic fibrosis. World J Gastroenterol 22:2779\u20132788. https:\/\/doi.org\/10.3748\/wjg.v22.i9.2779","journal-title":"World J Gastroenterol"},{"key":"5704_CR71","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1074\/jbc.RA119.012095","volume":"295","author":"SM Ebert","year":"2020","unstructured":"Ebert SM, Bullard SA, Basisty N, Marcotte GR, Skopec ZP, Dierdorff JM, Al-Zougbi A, Tomcheck KC, DeLau AD, Rathmacher JA, Bodine SC, Schilling B, Adams CM (2020) Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C\/EBPbeta. J Biol Chem 295:2787\u20132803. https:\/\/doi.org\/10.1074\/jbc.RA119.012095","journal-title":"J Biol Chem"},{"key":"5704_CR72","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/jcsm.12515","volume":"11","author":"JO Garnham","year":"2020","unstructured":"Garnham JO, Roberts LD, Espino-Gonzalez E, Whitehead A, Swoboda PP, Koshy A, Gierula J, Paton MF, Cubbon RM, Kearney MT, Egginton S, Bowen TS, Witte KK (2020) Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology. J Cachexia Sarcopenia Muscle 11:394\u2013404. https:\/\/doi.org\/10.1002\/jcsm.12515","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"5704_CR73","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-009-0643-5","volume":"458","author":"RJ Zeman","year":"2009","unstructured":"Zeman RJ, Zhao J, Zhang Y, Zhao W, Wen X, Wu Y, Pan J, Bauman WA, Cardozo C (2009) Differential skeletal muscle gene expression after upper or lower motor neuron transection. Pflugers Arch 458:525\u2013535. https:\/\/doi.org\/10.1007\/s00424-009-0643-5","journal-title":"Pflugers Arch"},{"key":"5704_CR74","doi-asserted-by":"publisher","first-page":"39422","DOI":"10.1074\/jbc.M305371200","volume":"278","author":"S Kovacic","year":"2003","unstructured":"Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR (2003) Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422\u201339427. https:\/\/doi.org\/10.1074\/jbc.M305371200","journal-title":"J Biol Chem"},{"key":"5704_CR75","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.tem.2011.05.001","volume":"22","author":"S Gray","year":"2011","unstructured":"Gray S, Kim JK (2011) New insights into insulin resistance in the diabetic heart. Trends Endocrinol Metab 22:394\u2013403. https:\/\/doi.org\/10.1016\/j.tem.2011.05.001","journal-title":"Trends Endocrinol Metab"},{"key":"5704_CR76","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.yjmcc.2010.12.007","volume":"50","author":"S Turdi","year":"2011","unstructured":"Turdi S, Kandadi MR, Zhao J, Huff AF, Du M, Ren J (2011) Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 50:712\u2013722. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.12.007","journal-title":"J Mol Cell Cardiol"},{"key":"5704_CR77","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/EJE-12-0632","volume":"167","author":"I Banerjee","year":"2012","unstructured":"Banerjee I, Avatapalle B, Petkar A, Skae M, Padidela R, Ehtisham S, Patel L, Rigby L, Flanagan S, Ellard S, Jones C, Ciotti G, Malaiya N, Clayton PE (2012) The association of cardiac ventricular hypertrophy with congenital hyperinsulinism. Eur J Endocrinol 167:619\u2013624. https:\/\/doi.org\/10.1530\/EJE-12-0632","journal-title":"Eur J Endocrinol"},{"key":"5704_CR78","doi-asserted-by":"publisher","first-page":"24194","DOI":"10.1074\/jbc.M802869200","volume":"283","author":"AY Chan","year":"2008","unstructured":"Chan AY, Dolinsky VW, Soltys CL, Viollet B, Baksh S, Light PE, Dyck JR (2008) Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283:24194\u201324201. https:\/\/doi.org\/10.1074\/jbc.M802869200","journal-title":"J Biol Chem"},{"key":"5704_CR79","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/cvr\/cvn316","volume":"81","author":"A Akki","year":"2009","unstructured":"Akki A, Seymour AM (2009) Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy. Cardiovasc Res 81:610\u2013617. https:\/\/doi.org\/10.1093\/cvr\/cvn316","journal-title":"Cardiovasc Res"},{"key":"5704_CR80","doi-asserted-by":"publisher","first-page":"R1560","DOI":"10.1152\/ajpregu.00392.2009","volume":"298","author":"LN Axelsen","year":"2010","unstructured":"Axelsen LN, Lademann JB, Petersen JS, Holstein-Rathlou NH, Ploug T, Prats C, Pedersen HD, Kjolbye AL (2010) Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol 298:R1560\u20131570. https:\/\/doi.org\/10.1152\/ajpregu.00392.2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5704_CR81","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cardiores.2004.02.013","volume":"63","author":"VP van Empel","year":"2004","unstructured":"van Empel VP, De Windt LJ (2004) Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc Res 63:487\u2013499. https:\/\/doi.org\/10.1016\/j.cardiores.2004.02.013","journal-title":"Cardiovasc Res"},{"key":"5704_CR82","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1038\/sj.onc.1208847","volume":"24","author":"M Gupta","year":"2005","unstructured":"Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebermann DA (2005) Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis. Oncogene 24:7170\u20137179. https:\/\/doi.org\/10.1038\/sj.onc.1208847","journal-title":"Oncogene"},{"key":"5704_CR83","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/1535370214531879","volume":"239","author":"L Zhang","year":"2014","unstructured":"Zhang L, Yang Z, Liu Y (2014) GADD45 proteins: roles in cellular senescence and tumor development. Exp Biol Med (Maywood) 239:773\u2013778. https:\/\/doi.org\/10.1177\/1535370214531879","journal-title":"Exp Biol Med (Maywood)"},{"key":"5704_CR84","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/ijc.21637","volume":"118","author":"G Schneider","year":"2006","unstructured":"Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S (2006) GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer 118:2405\u20132411. https:\/\/doi.org\/10.1002\/ijc.21637","journal-title":"Int J Cancer"},{"key":"5704_CR85","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1158\/0008-5472.CAN-10-2177","volume":"70","author":"JS Tront","year":"2010","unstructured":"Tront JS, Huang Y, Fornace AJ Jr., Hoffman B, Liebermann DA (2010) Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress. Cancer Res 70:9671\u20139681. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2177","journal-title":"Cancer Res"},{"key":"5704_CR86","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/cvr\/cvn243","volume":"81","author":"GW Dorn","year":"2009","unstructured":"Dorn GW 2 (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81:465\u2013473. https:\/\/doi.org\/10.1093\/cvr\/cvn243","journal-title":"Cardiovasc Res"},{"key":"5704_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12013-012-9462-y","volume":"66","author":"Y Shen","year":"2013","unstructured":"Shen Y, Song G, Liu Y, Zhou L, Liu H, Kong X, Sheng Y, Cao K, Qian L (2013) Silencing of FABP3 inhibits proliferation and promotes apoptosis in embryonic carcinoma cells. Cell Biochem Biophys 66:139\u2013146. https:\/\/doi.org\/10.1007\/s12013-012-9462-y","journal-title":"Cell Biochem Biophys"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05704-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:33:15Z","timestamp":1745980395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05704-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5704"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05704-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocols were approved by the Institutional Animal Care and Use Committee of the University of Barcelona, as stated in Law 5\/21 July 1995 passed by the Generalitat de Catalunya. All experimental procedures were performed in accordance with European Community Council directive 86\/609\/EEC, and followed the ARRIVE and the standard ethical guidelines []. Accordingly, all efforts were made to minimize the suffering and the number of mice used. The study followed the Declaration of Helsinki guidelines for biomedical research involving human subjects. The Institutional Ethics and Clinical Research Committee of Cantabria approved the study (internal authorization code PI21\/00084). All patients were informed verbally and through printed material about the nature of the study and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors commented on previous versions of the manuscript and approved the final manuscript. All authors have consented for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"189"}}